
Tiansheng
002872.SZTiansheng Pharmaceutical Group Co., Ltd. Price (002872.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
318,000,000
(0)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Tiansheng Pharmaceutical Group Co., Ltd.Currency: CNY
YEAR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
1,004,120,019.00
+0% |
1,421,960,059.00
+42% |
1,663,784,343.00
+17% |
1,843,015,280.00
+11% |
2,086,931,557.00
+13% |
2,261,414,376.00
+8% |
2,171,439,923.00
-4% |
1,678,052,466.00
-23% |
1,202,746,111.00
-28% |
736,685,771.00
-39% |
606,992,213.00
-18% |
579,334,659.00
-5% |
|||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 715,476,838.00 | 997,768,785.00 | 1,202,797,839.00 | 1,308,562,027.00 | 1,474,681,008.00 | 1,578,522,538.00 | 1,548,583,694.00 | 1,206,047,030.00 | 852,832,386.00 | 432,703,168.00 | 263,594,134.00 | 322,361,236.00 | |||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
288,643,181.00
+0% |
424,191,274.00
+47% |
460,986,504.00
+9% |
534,453,253.00
+16% |
612,250,549.00
+15% |
682,891,838.00
+12% |
622,856,229.00
-9% |
472,005,436.00
-24% |
349,913,725.00
-26% |
303,982,603.00
-13% |
343,398,079.00
+13% |
256,973,423.00
-25% |
|||||||
Gross Profit Ratio | (0.29%) | (0.30%) | (0.28%) | (0.29%) | (0.29%) | (0.30%) | (0.29%) | (0.28%) | (0.29%) | (0.41%) | (0.57%) | (0.44%) | |||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 14,682,600.00 | 25,153,100.00 | 19,126,340.00 | 21,179,101.00 | 35,118,413.00 | 33,857,937.00 | 39,782,371.00 | 36,286,833.00 | 22,456,265.00 | 29,243,734.00 | 34,269,392.00 | 30,916,051.00 | |||||||
General and Administrative | 68,708,972.00 | 106,298,643.00 | 23,164,140.00 | 21,237,977.00 | 22,856,302.00 | 30,137,505.00 | 29,208,086.00 | 44,490,605.00 | 51,338,036.00 | 32,351,547.00 | 35,964,826.00 | 32,972,860.00 | |||||||
Selling, General & Admin... | 159,315,614.00 | 228,533,059.00 | 159,501,824.00 | 172,908,087.00 | 202,600,429.00 | 221,343,866.00 | 399,462,222.00 | 454,634,675.00 | 351,819,776.00 | 260,781,526.00 | 303,047,898.00 | 316,458,784.00 | |||||||
Selling & Marketing Exp... | 90,606,642.00 | 122,234,416.00 | 136,337,683.00 | 151,670,109.00 | 179,744,127.00 | 191,206,361.00 | 370,254,135.00 | 410,144,069.00 | 300,481,739.00 | 228,429,978.00 | 267,083,072.00 | 180,276,888.00 | |||||||
Depreciation and Amortiz... | 34,744,800.00 | 49,334,900.00 | 59,818,326.00 | 65,656,814.00 | 83,677,600.00 | 106,882,622.00 | 115,074,411.00 | 116,722,935.00 | 121,950,145.00 | 93,243,302.00 | 110,484,633.00 | 107,259,515.00 | |||||||
Other Expenses | 23,222,664.00 | 20,503,366.00 | 27,492,574.00 | 41,014,869.00 | 39,212,724.00 | 57,516,705.00 | 66,475,068.00 | 82,914,350.00 | 71,374,917.00 | 47,344,352.00 | 70,490,398.00 | 3,171,589.00 | |||||||
Total Operating Expenses | 165,179,671.00 | 234,332,809.00 | 242,898,249.00 | 269,343,986.00 | 321,154,909.00 | 312,718,509.00 | 505,719,662.00 | 573,835,859.00 | 445,650,958.00 | 337,369,613.00 | 407,807,689.00 | 350,546,424.00 | |||||||
Cost and Exponses | 880,656,510.00 | 1,232,101,594.00 | 1,445,696,089.00 | 1,577,906,014.00 | 1,795,835,918.00 | 1,891,241,048.00 | 2,054,303,356.00 | 1,779,882,890.00 | 1,298,483,345.00 | 770,072,782.00 | 671,401,823.00 | 672,907,660.00 | |||||||
Operating Income | |||||||||||||||||||
Operating Income |
107,673,754.00
+0% |
149,634,940.00
+39% |
173,343,567.00
+16% |
206,921,583.00
+19% |
238,661,496.00
+15% |
309,648,479.00
+30% |
96,626,292.00
-69% |
-102,658,003.47
-206% |
-95,737,233.93
-7% |
-6,517,358.76
-93% |
-51,198,662.56
+686% |
-93,573,002.00
+83% |
|||||||
Operating Income Ratio | (0.11%) | (0.11%) | (0.10%) | (0.11%) | (0.11%) | (0.14%) | (0.04%) | (-0.06%) | (-0.08%) | (-0.01%) | (-0.08%) | (-0.16%) | |||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 17,138,750.00 | 0.00 | 4,193,404.00 | 1,276,323.00 | 1,298,273.00 | 2,161,639.00 | 2,015,537.00 | 1,456,870.00 | 5,923,593.00 | 16,842,451.00 | 7,518,521.00 | 8,397,891.00 | |||||||
Interest Expenses | 0.00 | 26,603,900.00 | 37,358,083.00 | 35,077,858.00 | 35,524,417.00 | 28,774,438.00 | 42,182,374.00 | 37,649,737.00 | 38,885,725.00 | 24,356,185.00 | 15,783,815.00 | 14,993,721.00 | |||||||
Total Other Income/Exp... | 7,376,394.00 | 19,273,104.00 | 27,008,677.00 | 39,679,075.00 | 39,203,852.00 | -4,407,487.00 | -59,581,188.00 | -9,114,180.48 | -34,235,522.34 | 6,547,347.00 | 589,944.00 | -1,150,031.55 | |||||||
EBITDA | |||||||||||||||||||
EBITDA | 158,208,311.00 | 239,193,365.00 | 264,934,173.00 | 302,958,885.00 | 397,842,579.00 | 427,969,071.00 | 187,729,864.00 | -82,279,636.00 | -370,226,777.00 | 59,904,233.00 | 39,319,799.00 | 27,530,204.00 | |||||||
EBITDA ratio | (0.16%) | (0.18%) | (0.19%) | (0.20%) | (0.19%) | (0.21%) | (0.09%) | (0.00%) | (-0.01%) | (0.11%) | (0.09%) | (0.05%) | |||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 130,839,905.00 | 168,908,044.00 | 200,352,244.00 | 246,600,658.00 | 276,925,978.00 | 305,250,636.00 | 37,045,104.00 | -229,636,909.36 | -534,578,327.57 | -54,444,322.89 | -84,116,138.13 | -94,723,033.55 | |||||||
Income Before Tax Ratio | (0.13%) | (0.12%) | (0.12%) | (0.13%) | (0.13%) | (0.13%) | (0.02%) | (-0.14%) | (-0.44%) | (-0.07%) | (-0.14%) | (-0.16%) | |||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 17,635,115.00 | 35,882,787.00 | 26,481,630.00 | 45,302,094.00 | 42,881,605.00 | 49,439,643.00 | 21,423,916.00 | -10,697,831.90 | -40,993,211.61 | 17,894,851.00 | 7,437,109.00 | -1,010,501.00 | |||||||
Net Income | |||||||||||||||||||
Net Income | 109,987,794.00
+0% |
125,948,051.00
+15% |
164,573,145.00
+31% |
191,977,863.00
+17% |
224,496,958.00
+17% |
248,575,376.00
+11% |
15,621,187.00
-94% |
-218,939,077.46
-1,502% |
-493,585,115.96
+125% |
-72,339,174.37
-85% |
-91,553,247.62
+27% |
-93,073,691.00
+2% |
|||||||
Net Income Ratio | (0.11%) | (0.09%) | (0.10%) | (0.10%) | (0.11%) | (0.11%) | (0.01%) | (-0.13%) | (-0.41%) | (-0.10%) | (-0.15%) | (-0.16%) | |||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.55 | 0.59 | 0.75 | 0.81 | 0.94 | 0.84 | 0.06 | -0.69 | -1.55 | -0.23 | -0.29 | -0.29 | |||||||
Diluted EPS | 0.55 | 0.59 | 0.75 | 0.81 | 0.94 | 0.84 | 0.06 | -0.69 | -1.55 | -0.23 | -0.29 | -0.29 | |||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 201,184,922.00 | 212,271,997.00 | 218,459,928.00 | 237,979,263.00 | 238,826,551.00 | 294,443,883.00 | 247,501,050.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 | |||||||
Diluted Share Outstanding | 201,197,186.00 | 212,271,997.00 | 218,459,928.00 | 237,989,087.00 | 238,826,551.00 | 294,443,883.00 | 247,501,050.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 | 318,000,000.00 |